Associated Papers
Comparative analysis of RNA expression in a single institution cohort of pediatric cancer patients.
Vasquez YA et al.
Npj Precision Oncology, 2025
Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas.
Barachini S et al.
Cancers, 2023
The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.
Davidson AL et al.
Genome Medicine, 2023
Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures.
Zhang X et al.
Frontiers in Immunology, 2023
Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.
Szpechcinski A et al.
Cancers, 2022
Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.
Qiu L et al.
Genes, 2022
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer.
Abdel-Wahab R et al.
Scientific Reports, 2020
C-KIT mutation in thymic carcinomas.
Terzi N et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists, 2020
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
McCabe MJ et al.
Scientific Reports, 2019
Finding driver mutations in cancer: Elucidating the role of background mutational processes.
Brown AL et al.
Plos Computational Biology, 2019
Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.
Deng Q et al.
Heliyon, 2018
Computational analysis reveals histotype-dependent molecular profile and actionable mutation effects across cancers.
Heim D et al.
Genome Medicine, 2018
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing.
Hagemann IS et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2014
Thymoma versus thymic carcinoma: differences in biology impacting treatment.
Kelly RJ
Journal of the National Comprehensive Cancer Network : Jnccn, 2013
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Schirosi L et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2012
Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroid.
Pan Y et al.
Human Pathology, 2012
Imatinib mesylate in thymic epithelial malignancies.
Palmieri G et al.
Cancer Chemotherapy and Pharmacology, 2012
Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
Girard N et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009